<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20111207008315N30</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2020-07-13</date_registration>
      <primary_sponsor>Tabriz University of Medical Sciences</primary_sponsor>
      <public_title>The effect of aromatherapy on hernia operation pain</public_title>
      <acronym></acronym>
      <scientific_title>Comparison the Effect of Lavender and Geranium (Pelargonium Graveolens) on Pain after Hernia Repair Surgery of Hospitalized Children under 1 Year: a Randomized Clinical Trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2019-06-22</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>60</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/48932</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: Subjects were recruited using the convenient method and then for randomization, sealed envelopes containing one of the letters A, B, C (a total of 60: 20 of each letter) were used, which were selected by the companion and according to the contents of the envelope indicated which group it belonged to, Blinding description: Participants and experiment doer ,evaluators were unaware of the contents of the essential oils.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Comparison the effect of lavender and geranium essential oil.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group; Lavender: When children enter the ward from the operating room, first their group is determined by the closed envelope method and immediately their pain is measured with FLACC pain tool by the researcher herself and then according to the ward routine section of acetaminophen as a painkiller.  Once again after the analgesic (Acetaminophen/Apotel) injection as ward routine, the patient's pain is measured and recorded. Then, at intervals of 1, 3, 6, 9 and 12 hours after the operation, lavender essential oil is inhaled five times and the pain is measured thirty minutes since inhalation starts or 20 minutes after ending the each aromatherapy. The packages (5 dark glasses) are prepared and coded under the supervision of a pharmacologist and by another person, and the researcher conducting the intervention does not know the nature of the essential oil in the containers. The container be placed in front of the patient's nose for 10 minutes at a distance of 10 cm. The data is analyzed in SPSS software. Intervention 2: Intervention group, geranium rose:  When children enter the ward from the operating room, first their group is determined by the closed envelope method and immediately their pain is measured with FLACC pain tool by the researcher herself and then according to the ward routine section of acetaminophen as a painkiller.  Once again after the analgesic (Acetaminophen/Apotel) injection as ward routine, the patient's pain is measured and recorded. Then, at intervals of 1, 3, 6, 9 and 12 hours after the operation, Geranium Rose essential oil is inhaled five times and the pain is measured thirty minutes since inhalation starts or 20 minutes after ending the each aromatherapy. The packages (5 dark glasses) are prepared and coded under the supervision of a pharmacologist and by another person, and the researcher conducting the intervention does not know the nature of the essential oil in the containers. The container be placed in front of the patient's nose for 10 minutes at a distance of 10 cm. The data is analyzed in SPSS software. Intervention 3: Control group, sweet almond placebo: When children enter the ward from the operating room, first their group is determined by the closed envelope method and immediately their pain is measured with FLACC pain tool by the researcher herself and then according to the ward routine section of acetaminophen as a painkiller.  Once again after the analgesic (Acetaminophen/Apotel) injection as ward routine, the patient's pain is measured and recorded. Then, at intervals of 1, 3, 6, 9 and 12 hours after the operation, sweet almond oil is inhaled five times and the pain is measured thirty minutes since inhalation starts or 20 minutes after ending the each aromatherapy. The packages (5 dark glasses) are prepared and coded under the supervision of a pharmacologist and by another person, and the researcher conducting the intervention does not know the nature of the essential oil in the containers. The container be placed in front of the patient's nose for 10 minutes at a distance of 10 cm. The data is analyzed in SPSS software.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>No - There is not a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for not sharing IPD is -</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Leila Valizadeh</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Shariati St. School of Nursing and Midwifery</address>
        <city>Tabriz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>51389477977</zip>
        <telephone>+98 41 3479 6770</telephone>
        <email>valizadehl@tbzmed.ac.ir</email>
        <affiliation>Tabriz University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Leila Valizadeh</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>School of Nursing and Midwifery, Shariati street.</address>
        <city>Tabriz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>5138947977</zip>
        <telephone>+98 41 3479 6770</telephone>
        <email>valizadehl@tbzmed.ac.ir</email>
        <affiliation>Tabriz University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Children hospitalized in the pediatric surgery department. Candidates for surgery are both male and female
Family satisfaction with their children's participation in the study
No respiratory problems such as asthma and allergic rhinitis
Having a companion in the children participating in the study
Children under one year old</inclusion_criteria>
      <agemin>2 months</agemin>
      <agemax>1 year</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Lack of cooperation between the patient and the patient's family during the intervention
The patient's death
Patient discharge before the intervention
Homeless and unaccompanied child
Sensitivity to the smell of lavender, geranium and sweet almond
The use of perfume and other fragrances by the child or with the child
Multiple surgeries
Children under 2 months</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Drugs</i_code>
      <i_code>Treatment - Drugs</i_code>
      <i_code>Treatment - Drugs</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group; Lavender: When children enter the ward from the operating room, first their group is determined by the closed envelope method and immediately their pain is measured with FLACC pain tool by the researcher herself and then according to the ward routine section of acetaminophen as a painkiller.  Once again after the analgesic (Acetaminophen/Apotel) injection as ward routine, the patient's pain is measured and recorded. Then, at intervals of 1, 3, 6, 9 and 12 hours after the operation, lavender essential oil is inhaled five times and the pain is measured thirty minutes since inhalation starts or 20 minutes after ending the each aromatherapy. The packages (5 dark glasses) are prepared and coded under the supervision of a pharmacologist and by another person, and the researcher conducting the intervention does not know the nature of the essential oil in the containers. The container be placed in front of the patient's nose for 10 minutes at a distance of 10 cm. The data is analyzed in SPSS software.</i_keyword>
      <i_keyword>Intervention group, geranium rose:  When children enter the ward from the operating room, first their group is determined by the closed envelope method and immediately their pain is measured with FLACC pain tool by the researcher herself and then according to the ward routine section of acetaminophen as a painkiller.  Once again after the analgesic (Acetaminophen/Apotel) injection as ward routine, the patient's pain is measured and recorded. Then, at intervals of 1, 3, 6, 9 and 12 hours after the operation, Geranium Rose essential oil is inhaled five times and the pain is measured thirty minutes since inhalation starts or 20 minutes after ending the each aromatherapy. The packages (5 dark glasses) are prepared and coded under the supervision of a pharmacologist and by another person, and the researcher conducting the intervention does not know the nature of the essential oil in the containers. The container be placed in front of the patient's nose for 10 minutes at a distance of 10 cm. The data is analyzed in SPSS software.</i_keyword>
      <i_keyword>Control group, sweet almond placebo: When children enter the ward from the operating room, first their group is determined by the closed envelope method and immediately their pain is measured with FLACC pain tool by the researcher herself and then according to the ward routine section of acetaminophen as a painkiller.  Once again after the analgesic (Acetaminophen/Apotel) injection as ward routine, the patient's pain is measured and recorded. Then, at intervals of 1, 3, 6, 9 and 12 hours after the operation, sweet almond oil is inhaled five times and the pain is measured thirty minutes since inhalation starts or 20 minutes after ending the each aromatherapy. The packages (5 dark glasses) are prepared and coded under the supervision of a pharmacologist and by another person, and the researcher conducting the intervention does not know the nature of the essential oil in the containers. The container be placed in front of the patient's nose for 10 minutes at a distance of 10 cm. The data is analyzed in SPSS software.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Pain score. Timepoint: 0, half hour after surgery without aromatherapy, and in 1,3,6,9,12 hours after surgery with aromatherapy. Method of measurement: FLACC pain rating scale.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Tabriz University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2018-09-10</approval_date>
        <contact_name>Tabriz University of Medical Sciences ethic committee</contact_name>
        <contact_address>Ethic committee, Research deputy building,Tabriz University of Medical Sciences, Golgasht Street, Azadi Street,Tabriz, East Azerbaijan, Iran., Tabriz East Azarbaijan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
